Dow Up0.51% Nasdaq Up0.24%

Nektar Therapeutics (NKTR)

-NasdaqGS
14.67 Up 0.35(2.44%) Nov 21, 4:00PM EST
|After Hours : 14.58 Down 0.09 (0.61%) Nov 21, 5:02PM EST
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingSep 30, 2014Jun 30, 2014Mar 31, 2014Dec 31, 2013
Total Revenue 132,871   28,513   19,771   31,146  
Cost of Revenue9,220  5,108  7,907  8,960  
Gross Profit 123,651   23,405   11,864   22,186  
Operating Expenses
Research Development34,200  36,702  38,338  48,248  
Selling General and Administrative9,130  9,619  9,928  9,832  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 80,321   (22,916) (36,402) (35,894)
Income from Continuing Operations
Total Other Income/Expenses Net127  96  312  100  
Earnings Before Interest And Taxes80,448  (22,820)(36,090)(35,794)
Interest Expense9,595  9,622  9,920  10,230  
Income Before Tax70,853  (32,442)(46,010)(46,024)
Income Tax Expense248  195  191  1,635  
Minority Interest -   -   -   -  
Net Income From Continuing Ops70,605  (32,637)(46,201)(47,659)
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 70,605   (32,637) (46,201) (47,659)
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 70,605   (32,637) (46,201) (47,659)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.